Alzamend Neuro, Inc. - 8-K Filing
Alzamend Neuro pauses Bipolar Disorder clinical trial following negative FDA feedback and terminates Statement of Work with Massachusetts General Hospital.
Alzamend Neuro pauses Bipolar Disorder clinical trial following negative FDA feedback and terminates Statement of Work with Massachusetts General Hospital.